Effects of advanced glycation end products (AGEs) on the differentiation potential of primary stem cells: a systematic review

Stem Cell Res Ther. 2023 Apr 11;14(1):74. doi: 10.1186/s13287-023-03324-5.

Abstract

The formation and accumulation of advanced glycation end products (AGEs) have been associated with aging and the development, or worsening, of many degenerative diseases, such as atherosclerosis, chronic kidney disease, and diabetes. AGEs can accumulate in a variety of cells and tissues, and organs in the body, which in turn induces oxidative stress and inflammatory responses and adversely affects human health. In addition, under abnormal pathological conditions, AGEs create conditions that are not conducive to stem cell differentiation. Moreover, an accumulation of AGEs can affect the differentiation of stem cells. This, in turn, leads to impaired tissue repair and further aggravation of diabetic complications. Therefore, this systematic review clearly outlines the effects of AGEs on cell differentiation of various types of primary isolated stem cells and summarizes the possible regulatory mechanisms and interventions. Our study is expected to reveal the mechanism of tissue damage caused by the diabetic microenvironment from a cellular and molecular point of view and provide new ideas for treating complications caused by diabetes.

Keywords: Advanced glycation end products; Differentiation; Review; Stem cells.

Publication types

  • Systematic Review
  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation
  • Diabetes Mellitus* / metabolism
  • Glycation End Products, Advanced* / metabolism
  • Glycation End Products, Advanced* / pharmacology
  • Humans
  • Receptor for Advanced Glycation End Products
  • Stem Cells / metabolism

Substances

  • Glycation End Products, Advanced
  • Receptor for Advanced Glycation End Products